NEPUVIBART
UNII 2G8MNM5LHS

Substance Identification & Data

This profile provides standardized clinical and technical data for Nepuvibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2G8MNM5LHS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2640224-48-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2G8MNM5LHS
CAS Registry Number
2640224-48-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NEPUVIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12235
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nepuvibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NEPUVIBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (237-ALANINE,238-ALANINE,332-GLYCINE,431-LEUCINE,437-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL ZRC-3308B10 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZRC-3308B10 .KAPPA.-CHAIN, DIMER
NEPUVIBART [INN]

Technical Codes

ZRC-3308B10